Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone

Andrologia

Volumn 40, Issue 4, 2008, Pages 259-264

  Yassin, A A ^a,b   Saad, F ^b,c   Gooren, L J ^d  

^a Segeberger Kliniken   (Germany)

^b GULF MEDICAL UNIVERSITY   (United Arab Emirates)

^c BAYER PHARMA AG   (Germany)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Erectile dysfunction; Metabolic syndrome; Testosterone

Indexed keywords

GLUCOSE; LIPID; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ABDOMINAL OBESITY; ANDROGEN DEFICIENCY; BONE MASS; CLINICAL TRIAL; DISEASE ASSOCIATION; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; GLUCOSE HOMEOSTASIS; HORMONE ACTION; HORMONE DEFICIENCY; HUMAN; HYPERTENSION; HYPOGONADISM; INSULIN RESISTANCE; LIBIDO; LIPID METABOLISM; METABOLIC SYNDROME X; MUSCLE MASS; NOTE; PENIS ERECTION; TESTOSTERONE BLOOD LEVEL;

AGING; DIABETES MELLITUS, TYPE 2; ERECTILE DYSFUNCTION; HUMANS; MALE; METABOLIC SYNDROME X; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TESTOSTERONE;

EID: 47749109127     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2008.00851.x     Document Type: Note

References (53)

1. Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI (2008) Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in non-obese aging men. J Clin Endocrinol Metab 93 : 139 146.
2. Araujo A, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, Mckinlay JB (2007) Sex steroids and all-cause mortality and cause-specific mortality in men. Arch Intern Med 167 : 1252 1260.
3. Bancroft J, Wu FC (1983) Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav 12 : 59 66.
4. Bansal TC, Guay AT, Jacobson J, Woods BO, Nesto RW (2005) Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction. J Sex Med 2 : 96 103.
5. Barrett-Connor E (1992) Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med 117 : 807 811.
6. Blouin K, Despres JP, Couillard C, Tremblay A, Prud'Homme D, Bouchard C, Tchernof A (2005) Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism 54 : 1034 1040.
7. Boyanov MA, Boneva Z, Christov VG (2003) Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 6 : 1 7.
8. Esmaillzadeh A, Mirmiran P, Azizi F (2006) Metabolic abnormalities identified by anthropometric measures in elderly men. Am J Clin Nutr 83 : 173 (author reply 173-174).
9. Hak AE, Witteman JC, De Jong FH, Geerlings MI, Hofman A, Pols HA (2002) Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 87 : 3632 3639.
10. Holden CA, McLachlan RI, Pitts M, Cumming R, Wittert G, Agius PA, Handelsman DJ, De Kretser DM (2005) Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 366 : 218 224.
11. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164 : 1066 1076.
12. Jones RD, Nettleship JE, Kapoor D, Jones HT, Channer KS (2005) Testosterone and atherosclerosis in aging men: purported association and clinical implications. Am J Cardiovasc Drugs 5 : 141 154.
13. Kalme T, Seppala M, Qiao Q, Koistinen R, Nissinen A, Harrela M, Loukovaara M, Leinonen P, Tuomilehto J (2005) Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J Clin Endocrinol Metab 90 : 1550 1556.
14. Khaw KT, Barrett-Connor E (1992) Lower endogenous androgens predict central adiposity in men. Ann Epidemiol 2 : 675 682.
15. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men. European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116 : 2694 2701.
16. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB (2006a) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91 : 843 850.
17. Kupelian V, Shabsigh R, Araujo AB, O'Donnell AB, McKinlay JB (2006b) Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts male aging study. J Urol 176 : 222 226.
18. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Salonen R, Rauramaa R, Salonen JT (2003) Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 149 : 601 608.
19. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27 : 1036 1041.
20. Laughlin GA, Barrett-Connor E, Bergstrom J (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93 : 68 75.
21. Liu PY, Death AK, Handelsman DJ (2003) Androgens and cardiovascular disease. Endocr Rev 24 : 313 340.
22. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Ling SM, Metter EJ, Artoni A, Carassale L, Cazzato A, Ceresini G, Guralnik JM, Basaria S, Valenti G, Ferrucci L (2007) Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med, 167 : 2249 2254.
23. Makinen J, Jarvisalo MJ, Pollanen P, Perheentupa A, Irjala K, Koskenvuo M, Makinen J, Huhtaniemi I, Raitakari OT (2005) Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol 45 : 1603 1608.
24. Marin P, Oden B, Bjorntorp P (1995) Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 80 : 239 243.
25. Muller M, Van Den Beld AW, Bots ML, Grobbee DE, Lamberts SW, Van Der Schouw YT (2004) Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 109 : 2074 2079.
26. Nieschlag E, Nieschlag S, Behre HM (1993) Lifespan and testosterone. Nature 366 : 215.
27. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25 : 55 60.
28. Page ST, Amory JK, DuBois Bowman F, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90 : 1502 1510.
29. Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D, Hayes FJ (2005) Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 90 : 2636 2641.
30. Saad F, Gooren L, Haider A, Yassin A (2007a) An exploratory study on the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome. Syst Biol Reprod Med 53 : 353 357.
31. Saad F, Kamischke A, Yassin A, Zitzmann M, Schubert M, Jockenhoevel F, Behre HM, Gooren L, Nieschlag E (2007b) More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate. Asian J Androl 9 : 291 297.
32. Saad F, Grahl AS, Aversa A, Yassin AA, Kadioglu A, Moncada I, Eardley I (2007c) Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction. BJU Int 99 : 988 992.
33. Saad F, Gooren L, Haider A, Yassin A (2008a) Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome. Andrologia 40 : 44 48.
34. Saad F, Gooren LJ, Haider A, Yassin A (2008b) A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl 29 : 102 105.
35. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 : 414 419.
36. Selvin E, Feinleib M, Zhang L, Rohrmann S, Rifai N, Nelson WG, Dobs A, Basaria S, Golden SH, Platz EA (2007) Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 30 : 234 238.
37. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H (2004) Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172 : 658 663.
38. Shabsigh R, Katz M, Yan G, Makhsida N (2005a) Cardiovascular issues in hypogonadism and testosterone therapy. Am J Cardiol 96 : 67M 72M.
39. Shabsigh R, Perelman MA, Lockhart DC, Lue TF, Broderick GA (2005b) Health issues of men: prevalence and correlates of erectile dysfunction. J Urol 174 : 662 667.
40. Shabsigh R, Rajfer J, Aversa A, Traish AM, Yassin A, Kalinchenko SY, Buvat J (2006) The evolving role of testosterone in the treatment of erectile dysfunction. Int J Clin Pract 60 : 1087 1092.
41. Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M (2008) Sexual health as a portal to men's health: a problem turned around into an opportunity. Int J Clin Pract 62 : 179 181.
42. Shores MM, Moceri VM, Gruenewald DA, Brodkin KI, Matsumoto AM, Kivlahan DR (2004) Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit. J Am Geriatr Soc 52 : 2077 2081.
43. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR (2006) Low serum testosterone and mortality in male veterans. Arch Intern Med 166 : 1660 1665.
44. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB (2000) Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23 : 490 494.
45. Svartberg J, Von Muhlen D, Sundsfjord J, Jorde R (2004) Waist circumference and testosterone levels in community dwelling men. The Tromso study. Eur J Epidemiol 19 : 657 663.
46. Tibblin G, Adlerberth A, Lindstedt G, Bjorntorp P (1996) The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 45 : 1605 1609.
47. Traish AM, Guay AT (2006) Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 3 : 382 404.
48. Van Pottelbergh I, Braeckman L, De Bacquer D, De Backer G, Kaufman JM (2003) Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. Atherosclerosis 166 : 95 102.
49. Wu FC, von Eckardstein A (2003) Androgens and coronary artery disease. Endocr Rev 24 : 183 217.
50. Yassin AA, Saad F (2006) Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido). World J Urol 24 : 639 644.
51. Yassin AA, Saad F (2007a) Erectile dysfunction, metabolic syndrome, hypogonadism are intertwined. J Urol 177 : 288.
52. Yassin AA, Saad F (2007b) Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only. J Sex Med, 4 : 497 501.
53. Yialamas MA, Dwyer AA, Hanley E, Lee H, Pitteloud N, Hayes FJ (2007) Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 92 : 4254 4259.